Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
China Isotope & Radiation Corp. ( (HK:1763) ) has shared an update.
China Isotope & Radiation Corporation (CIRC) has entered into a strategic cooperation agreement with CNNC Capital Holdings Limited to enhance the integration of the nuclear technology application industry chain. This collaboration aims to overcome technological bottlenecks and foster new productive forces through mergers, acquisitions, and equity investments, thereby empowering CIRC with financial capital for high-quality development.
The most recent analyst rating on (HK:1763) stock is a Buy with a HK$25.00 price target. To see the full list of analyst forecasts on China Isotope & Radiation Corp. stock, see the HK:1763 Stock Forecast page.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation (CIRC) operates in the nuclear technology industry, focusing on isotope and radiation applications. The company is involved in the development and integration of nuclear technology applications, aiming to enhance its market presence through strategic partnerships and financial empowerment.
Average Trading Volume: 377,911
Technical Sentiment Signal: Buy
Current Market Cap: HK$6.73B
See more data about 1763 stock on TipRanks’ Stock Analysis page.